๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2847549 33 F AL 06/27/2025 HPV9
 MERCK & CO. INC.
 2014790
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient was administered a 4th dose of HPV Gardasil 9 to left deltoid. No adverse reactions were not... Patient was administered a 4th dose of HPV Gardasil 9 to left deltoid. No adverse reactions were noted. Administration error was found before patient left the clinic and she was education on error. Instructed to contact clinic if any reactions occurred. No reports from patient. She actually returned to clinic on 6/10/2025for a visit and denied any problems or concerns related to the vaccine that was administered on 5/9/2025 More
2847550 19 M MI 06/27/2025 HEPA
 MERCK & CO. INC.
 Y014585
Underdose Underdose
19 year old was accidently given pediatric dose 19 year old was accidently given pediatric dose
2847551 82 M MI 06/27/2025 COVID19
 MODERNA
 3044069
Expired product administered Expired product administered
Resident was given vaccine that expired on 6/14/25. Resident monitored for any ill effects from vac... Resident was given vaccine that expired on 6/14/25. Resident monitored for any ill effects from vaccine and none were noted. More
2847552 11 M IL 06/27/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
 9PT2F
No adverse event, Wrong product administered No adverse event, Wrong product administered
Patient was given DTap instead of TDap. No adverse effects noted. Patient was given DTap instead of TDap. No adverse effects noted.
2847553 89 M MI 06/27/2025 COVID19
 MODERNA
 3044069
Expired product administered, No adverse event Expired product administered, No adverse event
Resident was given vaccine covid spikevax moderna that expired on 6/14/2025. Resident displayed no c... Resident was given vaccine covid spikevax moderna that expired on 6/14/2025. Resident displayed no complications related to vaccine. More
2847554 17 F SC 06/27/2025 MNQ
 SANOFI PASTEUR
 u8508aa
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
No reaction occurred after the MCV was administered to the patient. No reaction occurred after the MCV was administered to the patient.
2847555 10 M MI 06/27/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
 YC239
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
6/27/2025 DTap was given to a 10 year old patient. The DTap vaccine should not be administered to c... 6/27/2025 DTap was given to a 10 year old patient. The DTap vaccine should not be administered to children over the age of 7. This should have been a Td vaccine. More
2847556 32 F AL 06/27/2025 HPV9
 MERCK & CO. INC.
 X022735
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient was administered a fourth dose of HPV Gardasil 9 to right deltoid. No adverse reaction noted... Patient was administered a fourth dose of HPV Gardasil 9 to right deltoid. No adverse reaction noted. Administration error was discovered after patient left clinic. Patient was notified per phone call of error. Pt denies any adverse reactions. Counseled patient to notify clinic if she experiences any adverse side effects. She stated understanding. More
2847557 52 F IA 06/27/2025 PNC20
PNC20
 PFIZER\WYETH
PFIZER\WYETH
 LP4947
LP4947
Chills, Dizziness, Headache, Hyperhidrosis, Injection site erythema; Injection s... Chills, Dizziness, Headache, Hyperhidrosis, Injection site erythema; Injection site pain, Injection site warmth More
Patient developed softball size are of warmth and redness, pain at the injection site, headache, diz... Patient developed softball size are of warmth and redness, pain at the injection site, headache, dizziness, chills and sweats More
2847558 F IL 06/27/2025 RAB
 NOVARTIS VACCINES AND DIAGNOSTICS
 Unknown
Inappropriate schedule of product administration, Nasopharyngitis, Oral herpes Inappropriate schedule of product administration, Nasopharyngitis, Oral herpes
The patient received three doses of post-exposure Rabavert but did not receive any additional doses;... The patient received three doses of post-exposure Rabavert but did not receive any additional doses; Cold-like symptoms; Fever; Case reference number US-BN-2024-002393 is a spontaneous case initially received from a pharmacist via Med Communication (reference number: USBAV24-2095) on 23-Aug-2024 and concerns a female patient of unknown age. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient had unspecified rabies exposure. On 09-Aug-2024, unknown amount of time after rabies exposure, the patient was vaccinated with the first dose of RabAvert (batch number: unknown), at an unknown dose, route or site of administration for post exposure treatment. On 12-Aug-2024, unknown amount of time after rabies exposure, the patient was vaccinated with the second dose of RabAvert (batch number: unknown), at an unknown dose, route or site of administration. On 16-Aug-2024, unknown amount of time after rabies exposure, the patient was vaccinated with the third dose of RabAvert (batch number: unknown), at an unknown dose, route or site of administration. On an unspecified date, reported two days ago, the patient experienced fever and cold like symptoms. As reported patient did not receive any additional doses and reporter asked for recommendation in case of a delayed last dose (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient recovered from the events fever and cold symptoms. The reporter assessed the events of fever and cold symptoms as non-serious and possibly related to RabAvert. No further information was provided.; Reporter's Comments: A female patient of unknown age experienced non-serious events of fever and cold like symptoms on an unspecified date after the patient was vaccinated with the third dose of RabAvert for post exposure treatment. As reported the patient did not receive any additional doses, which is considered as inappropriate schedule of vaccine administered. Pyrexia is listed and expected for RabAvert per CCDS v4 and USPI, whilst nasopharyngitis is unlisted and unexpected. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. The outcome was unknown. Considering implied temporal relationship and since the contributory role of the suspect vaccine cannot be excluded, the reported events have been considered as related to RabAvert. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unknown age experienced non-serious events of fever and cold like symptoms on an unspecified date after the patient was vaccinated with the third dose of RabAvert for post exposure treatment. As reported the patient did not receive any additional doses, which is considered as inappropriate schedule of vaccine administered. Pyrexia is listed and expected for RabAvert per CCDS v4 and USPI, whilst nasopharyngitis is unlisted and unexpected. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. The outcome was unknown. Considering implied temporal relationship and since the contributory role of the suspect vaccine cannot be excluded, the reported events have been considered as related to RabAvert. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious. More
2847559 35 M MO 06/27/2025 TDAP
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 KR75K
KR75K
Diplopia, Dizziness, Feeling hot, Hypotonia, Impaired driving ability; Muscle ri... Diplopia, Dizziness, Feeling hot, Hypotonia, Impaired driving ability; Muscle rigidity, Snoring, Unresponsive to stimuli More
Immunization was given in exam room. Then patient was escorted to lab for blood draw. He was sitting... Immunization was given in exam room. Then patient was escorted to lab for blood draw. He was sitting at lab station when he became limp an unresponsive. LPN notified provider immediately, his legs were elevated, he was snoring and non responsive, Carotid pulse was strong. After about one min he became rigid and almost slipped out of his chair and then became responsive. He recognized that he passed out and felt hot, double vision and woozy. He was given water and juice and an ice pack. He still did not quite feel up for driving but was able to walk to an exam room to lay down for a few min. Repeat vitals were normal/consistent with arrival vitals. After about 45 min he felt better be still somewhat dizzy. He was able to walk to his wife's car and she drove home. More
2847560 55 F MD 06/27/2025 PNC21
 MERCK & CO. INC.
Cellulitis, Erythema, Pain in extremity, Peripheral swelling, Skin warm Cellulitis, Erythema, Pain in extremity, Peripheral swelling, Skin warm
Cellulitis. My right arm swelled and reddened almost immediately, and became extremely hot and painf... Cellulitis. My right arm swelled and reddened almost immediately, and became extremely hot and painful. The swelling, redness, and heat has continued to spread for 5 days, with constant pain. I received a diagnosis of cellulitis and was prescribed Keflex on June 26, 2025. Here is the provider's note: Skin: General Skin rash, erythema, and abnormally warm. Rash: site of rash: (r arm). Assessment / Plan 1. Acute cellulitis presentation favoring cellulitis vs delayed cutaneous adverse reaction from capvaxie shot. Site is blanchable but spreading per pt. Will treat with Keflex and triamcinolone cream. Will let me know how she's feeling tomorrow. will continue to use ice, tylenol. advil. L03.90: Cellulitis, unspecified cephalexin 500 mg capsule - Take 1 capsule(s) every 12 hours by oral route for 5 days. Qty: (10) capsule. 2. Adverse effect of vaccine, initial encounter capvaxie vaccine T50.Z95A: Adverse effect of other vaccines and biological substances, initial encounter 3. Adverse effect of pneumococcal vaccine, initial encounter Capvaxie vaccine T50.A95A: Adverse effect of other bacterial vaccines, initial encounter Patient Instructions I've added on a steroid cream that may help clear the area sooner. More
2847561 1.92 M 06/27/2025 DTAP
HEPA
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 9PT2F
L9R92
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event More
no symptoms and no reactions, just a uncessary does of DTAP given off schedule. no symptoms and no reactions, just a uncessary does of DTAP given off schedule.
2847562 19 F OH 06/27/2025 HEP
MMR
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 K4JH7
X026219
Dizziness, Muscle contractions involuntary, Musculoskeletal stiffness, Pallor, U... Dizziness, Muscle contractions involuntary, Musculoskeletal stiffness, Pallor, Urinary incontinence; Dizziness, Muscle contractions involuntary, Musculoskeletal stiffness, Pallor, Urinary incontinence More
She got her vaccines this morning, she was sitting for a couple of mins and when she was checking ou... She got her vaccines this morning, she was sitting for a couple of mins and when she was checking out at the front desk she got light headed and then sat down, her body locked up she got really stiff, her arms curled up and it looked like she was having a seizure and she lost control of Blatter and looked really pale. We did call EMS because of the possible seizure they came and check her out and she decline to go the to ER. More
2847563 11 M AZ 06/27/2025 HPV9
MNQ
TDAP
 MERCK & CO. INC.
SANOFI PASTEUR
SANOFI PASTEUR
 Y012865
U8438AA
U8252AA
Immediate post-injection reaction, Urticaria; Immediate post-injection reaction,... Immediate post-injection reaction, Urticaria; Immediate post-injection reaction, Urticaria; Immediate post-injection reaction, Urticaria More
Hives on arms, neck, face, and legs immediately after vaccines were given Hives on arms, neck, face, and legs immediately after vaccines were given
2847564 1 M AL 06/27/2025 HIBV
HIBV
MMRV
MMRV
PNC20
PNC20
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
PFIZER\WYETH
PFIZER\WYETH
 Y016315
Y016315
Y019171
Y019171
LX4483
LX4483
Decreased appetite, Erythema, Injection site erythema, Injection site macule, In... Decreased appetite, Erythema, Injection site erythema, Injection site macule, Injection site swelling; Lethargy, Productive cough, Pruritus, Pyrexia; Decreased appetite, Erythema, Injection site erythema, Injection site macule, Injection site swelling; Lethargy, Productive cough, Pruritus, Pyrexia; Decreased appetite, Erythema, Injection site erythema, Injection site macule, Injection site swelling; Lethargy, Productive cough, Pruritus, Pyrexia More
MOP reported pt had a slight fever for a few days following the injections. Pt also had a wet cough... MOP reported pt had a slight fever for a few days following the injections. Pt also had a wet cough that turned dry over the past week. He was given tylenol prn for the fevers (highest was 102, tracking around 100 degrees F). This morning around 0700 (27 June), pt presented with mild, eurythmic raised macules on his inner right thigh. By 1045, it had spread to cover most of his thighs, parts of his inner arms, and a couple of spots on the top of his feet. Pt did not react when touched and MOP reported he has not been scratching the areas. MOP states pt has been lethargic this past week and has decreased appetite. Provider administered Benadryl during appt (apx 1055). by 1115, the rash had started to subside. More
2847565 61 F ID 06/27/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Uveitis Uveitis
uveitis uveitis
2847566 10 F MI 06/27/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 h4279
Extra dose administered, No adverse event Extra dose administered, No adverse event
no adverse reaction noted. no adverse reaction noted.
2847567 0.33 F IA 06/27/2025 DTPPVHBHPB
PNC20
 MSP VACCINE COMPANY
PFIZER\WYETH

Fatigue, Pyrexia, Somnolence, Vomiting; Fatigue, Pyrexia, Somnolence, Vomiting Fatigue, Pyrexia, Somnolence, Vomiting; Fatigue, Pyrexia, Somnolence, Vomiting
Child was sleepy on the hour drive home after vaccinations were administered. She napped most of the... Child was sleepy on the hour drive home after vaccinations were administered. She napped most of the drive home and was more tired than usual that afternoon. She took her afternoon nap and vomited 1-2 Tbsp of partially digested breast milk (no blood or discoloration) shortly after waking up around 3pm. She had a fever of 100.5F at 6:30pm on 29Jan2015. She vomited in her sleep some time between 10pm 29Jan2025 and 6am 30Jan2025. No treatment was administered for vomiting. No additional bouts of vomiting occurred after this instance. Body temperature reduced to 99.7F by 7:15pm on 30Jan2015. Elevated body temperature resolved by 8pm 31Jan2025 without intervention. More
2847568 74 F 06/27/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
 P2443
Joint range of motion decreased, Musculoskeletal stiffness Joint range of motion decreased, Musculoskeletal stiffness
patient complains of stiffness and decreased ROM in arm. pt has been taking OTC pain medication, whi... patient complains of stiffness and decreased ROM in arm. pt has been taking OTC pain medication, which has been helping. pt states they side effect is going away and improving. More
2847569 29 M AS 06/27/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 FH8027
FH8027
FH8027
FH8027
FH8027
FH8027
FH8027
FH8027
FH8027
FH8027
FH8027
Abdominal pain, Acute myocardial infarction, Alanine aminotransferase increased,... Abdominal pain, Acute myocardial infarction, Alanine aminotransferase increased, Angiogram pulmonary normal, Antineutrophil cytoplasmic antibody negative; Antinuclear antibody negative, Arthralgia, Aspartate aminotransferase increased, Atelectasis, Back pain; C-reactive protein increased, CSF test abnormal, Chest pain, Chills, Complement factor C3; Complement factor C4, Complement factor normal, Computerised tomogram thorax, Culture, Cytokine storm; Decreased appetite, Dyspnoea, Ear pain, Echocardiogram normal, Enteritis; Flank pain, HIV test negative, Headache, Leukopenia, Liver injury; Magnetic resonance imaging heart normal, Meningitis viral, Musculoskeletal stiffness, Myocarditis, Nasopharyngitis; Nausea, Oropharyngeal pain, Ovarian cyst ruptured, Petechiae, Pleural effusion; Pulmonary oedema, Pyrexia, Rash, Rash erythematous, Rheumatoid factor negative; SARS-CoV-2 test negative, Serum ferritin increased, Sinus disorder, Still's disease, Tachycardia; Troponin increased More
1/9/2022: ER c/o 1.5 weeks cold/sinus symptoms with negative covid antigen. Left ear pain, ha, naus... 1/9/2022: ER c/o 1.5 weeks cold/sinus symptoms with negative covid antigen. Left ear pain, ha, nausea, mild abd pain. 1/11-15/2022: 3rd ER visit with rt flank pain, nausea, dec appetite๏ฟฝ..febrile (103), tachycardia, chills, neck stiffness, back pain, SOB๏ฟฝ [has hx of LBP, bilat breast prostheses, and migraines (PTSD/concussions) per med record review]. see below Assigned case number (redacted) Nov 17, 2021 Pfizer covid vaccine 12/14/21 Pfizer covid vaccine 1/9/2022: ER c/o 1.5 weeks cold/sinus symptoms with negative covid antigen. Left ear pain, ha, nausea, mild abd pain. 1/11-15/2022: 3rd ER visit with rt flank pain, nausea, dec appetite๏ฟฝ..febrile (103), tachycardia, chills, neck stiffness, back pain, SOB๏ฟฝ [has hx of LBP, bilat breast prostheses, and migraines (PTSD/concussions) per med record review]. ER found partial rupt ovarian cyst, bilat basilar atelectatic, CSF study consistent with viral meningitis (see 1/11/2022 note) Dx viral meningitis and enteritis ๏ฟฝ admitted ๏ฟฝ seen by dermatology for truck/extremity salmon colored petechial rash.(1/19/2022 note-was on mult antibiotics, antiviral, NSAID, opioids, IV contrast, etc) --- 1/23/2022 discharge diagnoses: Adult onset stills disease, viral meningitis, enteritis, NSTEMII type 2, pulmonary edema, and acute hepatic injury 3/2022: 29yo AD Female referred to rheumatology for evaluation of AOSD. COVID vaccination in Jan developed cytokine storm like symptoms ultimately requiring hospitalization in early Jan m/b quotidian fevers, evanescent rash, leukopenia, arthralgias, pleural effusion, sore throat, myocarditis, high AST/ALT. Started on high dose steroids and increasing MTX at this time. Prednisone self tapered to 20mg daily and currently on 10mg weekly of MTX. pertinent positives include: Ferritin >4000-- >1321-- >82, CRP 36-- >2.7-- >.28, Negative ANA, RF, ANCA, HIV, C3/4, cultures. Radiology studies: Negative for lymphadenopathy by CTPA. Apr-May 2022: dx myocarditis: normal echo, cardiac MRI 2 months after onset chest pain, no significant findings noted in symptoms along with elevated troponin "are most consistent with a dx of myocarditis" after covid vaccine. Also diagnosed with AOSD on prednisone and methotrexate. 3/14/2025 Allergist documented discussion with Medical director Dr. advising "no evidence to extrapolate her request to all vaccines" but was granted exemption to covid-19 vaccinations. Case referred "formally to the (redacted)" per MD and he provided contact information to this patient. 6/27/2025: Continues to be seen by rheumatology, cardiology, neurology, psych, PCP and followed by case manager at facility. No contact from this patient to (redacted). More
โœ“
2847570 8 F ID 06/27/2025 TDAP
 SANOFI PASTEUR
 3CA30C1
Extra dose administered Extra dose administered
Patient and mom presented to our office for 8 year WCC and mom provided me with historic record of i... Patient and mom presented to our office for 8 year WCC and mom provided me with historic record of immunizations. Prior to determining if patient was due, these were entered into the chart so that it could be reconciled with system to determine if any are due. After completion of entry, it showed me that patient was due for TDaP next dose. We proceeded with administration of this immunization after permission obtained with mom, patient tolerated and left. Upon further review, it shows that this was a duplicate/invalid administration as patient had previously been up to date with vaccines. I believe the system had not had a chance to completely reconcile the outside data entry leading to erroneous duplication of vaccine. Moving forward, more attention to detail to allow system to fully update and review current immunization counts compared to how many should be due manually would be prudent to help prevent this moving forward when reviewing historic/current immunizations due. Patient's mom to be notified of duplication, no action required for recovery. More
2847571 0.5 F IA 06/27/2025 DTPPVHBHPB
PNC20
 MSP VACCINE COMPANY
PFIZER\WYETH

Fatigue, Pyrexia, Somnolence, Vomiting; Fatigue, Pyrexia, Somnolence, Vomiting Fatigue, Pyrexia, Somnolence, Vomiting; Fatigue, Pyrexia, Somnolence, Vomiting
Patient was sleepy on the hour drive home after vaccinations were administered. She napped most of t... Patient was sleepy on the hour drive home after vaccinations were administered. She napped most of the drive home and was more tired than usual that afternoon. She vomited 1-2 Tbsp of partially digested breast milk (no blood or discoloration) at 7:45pm. She had a fever of 100.7F at 8pm on 02Apr2025 No treatment was administered for vomiting. No additional bouts of vomiting occurred after this instance. Body temperature reduced to 99.7F by 7:15pm on 03Apr2025 without intervention and was normal by 12pm 04Apr2025. More
2847572 57 F NV 06/27/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Herpes zoster; Herpes zoster Herpes zoster; Herpes zoster
After being vaccinated, in 2024 I developed shingles requiring medical treatment After being vaccinated, in 2024 I developed shingles requiring medical treatment
2847573 86 M PA 06/27/2025 COVID19
RSV
 MODERNA
GLAXOSMITHKLINE BIOLOGICALS
 3046734
X773H
Expired product administered; Expired product administered Expired product administered; Expired product administered
Additional dose of AREXVY beyond the single recommended dose Additional dose of AREXVY beyond the single recommended dose
2847574 95 M PA 06/27/2025 COVID19
RSV
 MODERNA
GLAXOSMITHKLINE BIOLOGICALS
 3046734
X773H
Inappropriate schedule of product administration; Inappropriate schedule of prod... Inappropriate schedule of product administration; Inappropriate schedule of product administration More
Patient received additional dose of AREXVY in addition to the initial recommended dose - Doses were ... Patient received additional dose of AREXVY in addition to the initial recommended dose - Doses were approximately 16 months apart. More
2847575 F IL 06/27/2025 RAB
 NOVARTIS VACCINES AND DIAGNOSTICS
 Unknown
Inappropriate schedule of product administration Inappropriate schedule of product administration
The patient received the second dose of RabAvert vaccine in the middle of the night between day thre... The patient received the second dose of RabAvert vaccine in the middle of the night between day three to day four; Case reference number US-BN-2024-002407 is a spontaneous case initially received from consumer via Med Communication (reference number USBAV24-2110) on 26-Aug-2024 and concerns a female patient of unknown age. The patient's medical history and concomitant medication were not provided. On an unspecified date, the patient received the first dose of RabAvert (batch number: unknown), at an unknown dose, route or site of administration, for rabies vaccination. As reported, the patient went to emergency room (ER) for the first dose and was told that following doses could be administered in urgent care. The patient was out of town when got first dose of RabAvert and found that it was very hard to find any urgent care in patient's area that carries this brand of vaccine. On an unspecified date, reported as in the middle of the night, between day three and day four, the patient received the second dose of RabAvert (batch number: unknown), at an unknown dose, route or site of administration (explicitly coded ' Inappropriate schedule of vaccine administered'). As reported, the patient went where the first dose was administered, for fear of keeping the same manufacture through the series. At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert vaccine. No further information was provided.; Reporter's Comments: A female patient of unknown age received the second dose of RabAvert for rabies vaccination, reported as in the middle of the night, between day three and day four, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unknown age received the second dose of RabAvert for rabies vaccination, reported as in the middle of the night, between day three and day four, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious. More
2847576 73 F PA 06/27/2025 PNC21
 MERCK & CO. INC.
 Z004302
Feeling hot, Injection site warmth, Pyrexia Feeling hot, Injection site warmth, Pyrexia
The patient presents for evaluation of a reaction to a pneumonia vaccine. Reaction to pneumonia vac... The patient presents for evaluation of a reaction to a pneumonia vaccine. Reaction to pneumonia vaccine - She received the vaccine on 06/23/2025, followed by blood work. - She reports no pain but notes warmth at the injection site. - On the first night post-vaccination, she experienced a fever, managed with aspirin, and felt warm throughout the night. - No new rashes, but mentions a pre-existing rash around her neck. More
2847577 86 M PA 06/27/2025 COVID19
RSV
 MODERNA
GLAXOSMITHKLINE BIOLOGICALS
 3046734
X773H
Inappropriate schedule of product administration; Inappropriate schedule of prod... Inappropriate schedule of product administration; Inappropriate schedule of product administration More
Patient received additional dose of AREXVY in addition to the single dose recommended - doses were a... Patient received additional dose of AREXVY in addition to the single dose recommended - doses were approximately 19 months apart. More
2847578 85 F PA 06/27/2025 COVID19
RSV
 MODERNA
GLAXOSMITHKLINE BIOLOGICALS
 3046734
X773H
Inappropriate schedule of product administration; Inappropriate schedule of prod... Inappropriate schedule of product administration; Inappropriate schedule of product administration More
Patient received additional dose of AREXVY in addition to single dose recommended - doses were appro... Patient received additional dose of AREXVY in addition to single dose recommended - doses were approximately 19 months apart More
2847579 73 F NJ 06/27/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 3273H
Rash Rash
She started having rashes around her belly button on 6/20. Symptoms are getting better She started having rashes around her belly button on 6/20. Symptoms are getting better
2847580 62 F OK 06/27/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 J32PB
Extra dose administered, No adverse event Extra dose administered, No adverse event
The patient came in with their house assistant seeking to get a Prevnar 20 vaccine and a Shingles va... The patient came in with their house assistant seeking to get a Prevnar 20 vaccine and a Shingles vaccine. The Prevnar vaccine had been given previously so we informed them of that, however the shingles vaccination history was missed. A claim was run and approved and the vaccine was given. When looking through the patient history, it was discovered that the patient had already received two doses of Shingrix. The house manager was notified and told to watch for any issues with the third dose. There have been no reported adverse effects from the vaccine reported as of the writing of this summary. We will follow up over the next several days-weeks with the patient to ensure that no harmful side effects were experienced. If the patient has any additional symptoms we will notify VAERS immediately. More
2847581 1.08 M OH 06/27/2025 MMR
 MERCK & CO. INC.
Chest X-ray, Culture urine, Pyrexia, Respiratory pathogen panel, Urine analysis Chest X-ray, Culture urine, Pyrexia, Respiratory pathogen panel, Urine analysis
fever and possible rash starting on 6/22-6/26 fever and possible rash starting on 6/22-6/26
2847582 50 F MN 06/27/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 x5t42
Erythema, Pain in extremity, Peripheral swelling, Skin warm Erythema, Pain in extremity, Peripheral swelling, Skin warm
Patient received shingrix vaccine in left arm on 6-23-25. she returned to the pharmacy on 6-27-25 st... Patient received shingrix vaccine in left arm on 6-23-25. she returned to the pharmacy on 6-27-25 stating her was experiencing pain, redness, warmth and swelling in the left arm. She also stated the area had gotten larger. She reported she did not have a fever. Rph explained this may be a normal reaction to the vaccine but advised a nurse consult at the clinic. Pharmacist walked her to the clinic to advise about an ancillary visit, but patient did not have time to wait. she was advised to call the clinic as soon as possible for advice. She was also advised to go to urgent care or emergency room if symptoms worsened or if she developed a fever. patient acknowledged understanding. More
2847583 77 F CO 06/27/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 Y7XG3
Injection site pain, Injection site rash, Pain, Pain in extremity Injection site pain, Injection site rash, Pain, Pain in extremity
She started developing soreness in the left arm and down left side the night of 6/26/25. She noticed... She started developing soreness in the left arm and down left side the night of 6/26/25. She noticed the rash in the morning of 6/27/25. It is below the injection site and about 2 inches in diameter with a couple smaller spots around it. It doesn't itch, it's just tender. More
2847584 4 F MI 06/27/2025 VARCEL
 MERCK & CO. INC.
 Y017915
Extra dose administered, Streptococcus test positive, Wrong product administered Extra dose administered, Streptococcus test positive, Wrong product administered
Patient given incorrect vaccine outside of the order from the provider. It is patient's 3rd dos... Patient given incorrect vaccine outside of the order from the provider. It is patient's 3rd dose of Varivax. Patient also tested positive for Strep Throat in office during visit. More
2847585 1.25 M SC 06/27/2025 DTAPIPVHIB
PNC15
 SANOFI PASTEUR
MERCK & CO. INC.
 UK228AB
Z003633
Injection site bruising, Injection site erythema, Injection site pain, Injection... Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling; Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling More
15-MONTH-OLD RECIEVED VACCINES 2 DAYS AGO. MOTHER CALLED STATING SHE NOTICED LEFT LEG REDNESS, SWELL... 15-MONTH-OLD RECIEVED VACCINES 2 DAYS AGO. MOTHER CALLED STATING SHE NOTICED LEFT LEG REDNESS, SWELLING, AND TENDERNESS AT SITE OF INJECTION. TODAY IN OFFICE PURPLE/RED DISCOLORATION AND BRUISING SEEN AT 5CM AWAY FROM INJECTION SITE PER PROVIDER. TREATMENT IS SUPPORTIVE CARE/MONITORING. More
2847586 21 F TX 06/27/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
 945660
Pruritus, Urticaria Pruritus, Urticaria
Employee noted hives around the left flank and left lower back around 1900 when taking a shower, the... Employee noted hives around the left flank and left lower back around 1900 when taking a shower, the day following the vaccination on 06/21/2025. Employee states that there was mild itching at the left flank and lower back. Employee denies any redness and itching at the injection site. Employee denies seeking medical attention for the itching. Employee applied Vaseline and CeraVe body lotion to the hives to alleviate itching. More
2847587 73 F OH 06/27/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 3x97j
Injection site rash Injection site rash
Rash on left arm near injection site. Pt will monitor and let us know of any changes. Rash on left arm near injection site. Pt will monitor and let us know of any changes.
2847588 63 M GA 06/27/2025 TD
 SANOFI PASTEUR
 U8491AA
Arthralgia, Asthenia, Musculoskeletal stiffness, Myalgia, Tendon pain Arthralgia, Asthenia, Musculoskeletal stiffness, Myalgia, Tendon pain
DIFFUSE SEVERE JOINT PAIN , STIFFNESS, WEAKNESS, FOLOWED BY TENDON AND MUSCLE PAIN X 4 DAYS DIFFUSE SEVERE JOINT PAIN , STIFFNESS, WEAKNESS, FOLOWED BY TENDON AND MUSCLE PAIN X 4 DAYS
2847589 4 F GA 06/27/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 5G23D
Z006282
Injection site rash, Rash erythematous, Rash papular; Injection site rash, Rash ... Injection site rash, Rash erythematous, Rash papular; Injection site rash, Rash erythematous, Rash papular More
About 10 minutes after vaccine administration patient developed a nonpruritic rash on her face only.... About 10 minutes after vaccine administration patient developed a nonpruritic rash on her face only. The rash was mildly erythematous and raised. There was no difficulty breathing, throat swelling or pain, pruritus. Patient was evaluated immediately after and provided Benadryl. Patient was walking and talking at baseline. A prescription was sent for Benadryl and prednisone if symptoms worsen. Patient's parent was given strict ED precautions. More
2847590 27 F MO 06/27/2025 HEPA
 MERCK & CO. INC.
 X026485
Expired product administered Expired product administered
Patient was administered vaccine on 6/27/25 but the expiration date was 5/11/25. Patient was administered vaccine on 6/27/25 but the expiration date was 5/11/25.
2847591 1 M WA 06/27/2025 MMRV
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
 y017513
y015100
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event More
gave MMR-V and Varicella at the sametime, no reaction reported gave MMR-V and Varicella at the sametime, no reaction reported
2847592 0.5 M AL 06/27/2025 DTAPIPVHIB
 SANOFI PASTEUR
 uk167aa
No adverse event, Wrong product administered No adverse event, Wrong product administered
patient was given a dose of pentacel by mistake at last checkup. pt with no complications reported ... patient was given a dose of pentacel by mistake at last checkup. pt with no complications reported by mother. More
2847593 58 M NJ 06/27/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 ER8733
ER8733
ER8733
ER8733
ER8733
ER8733
ER8731
ER8731
ER8731
ER8731
ER8731
ER8731
Abdominal X-ray, Autonomic nervous system imbalance, Blindness transient, Blood ... Abdominal X-ray, Autonomic nervous system imbalance, Blindness transient, Blood test, Bradycardia; COVID-19, Cardiac stress test, Chest X-ray, Computerised tomogram head, Computerised tomogram thorax; Deep vein thrombosis, Dizziness, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory; Electrocochleogram, Electroencephalogram, Fatigue, Magnetic resonance imaging head, Meniere's disease; Postural orthostatic tachycardia syndrome, Presyncope, Syncope, Tachycardia, Tilt table test positive; Ultrasound Doppler, Vertigo; Abdominal X-ray, Autonomic nervous system imbalance, Blindness transient, Blood test, Bradycardia; COVID-19, Cardiac stress test, Chest X-ray, Computerised tomogram head, Computerised tomogram thorax; Deep vein thrombosis, Dizziness, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory; Electrocochleogram, Electroencephalogram, Fatigue, Magnetic resonance imaging head, Meniere's disease; Postural orthostatic tachycardia syndrome, Presyncope, Syncope, Tachycardia, Tilt table test positive; Ultrasound Doppler, Vertigo More
4-13-21; Driven home from work with lightheadedness 6-03-21; DVTs in right leg 8-05-21; Driven home ... 4-13-21; Driven home from work with lightheadedness 6-03-21; DVTs in right leg 8-05-21; Driven home from work with lightheadedness, near syncope 8-10-21; Driven to hospital from work with lightheadedness, near syncope. O/N in hospital --tachychardia Through 2022--Continued issues with lightheadedness, transient vision obscurations TVO's), and unexplained autonomic dysfunction 5-25-22; Failed Tilt Table Test-- POTS diagnosis 5-25-22; FIRST TIME COVID DIAGNOSIS 10-13-22; Ambulance from work--1st Vertigo attack--After several months, diagnosed with Meniere's Continues to-date with same issues--now calling it "Vaso Depressor Syncope," Bradychardia, fatigue More
โœ“ โœ“
2847594 5 F ND 06/27/2025 COVID19
 PFIZER\BIONTECH
 LN7302
Product storage error Product storage error
Error during transport caused vaccine to be deemed invalid Error during transport caused vaccine to be deemed invalid
2847595 F KS 06/27/2025 RAB
 NOVARTIS VACCINES AND DIAGNOSTICS
 FDP00555
Incorrect route of product administration, No adverse event Incorrect route of product administration, No adverse event
The patient received second dose of RabAvert vaccine subcutaneously instead of intramuscularly; Case... The patient received second dose of RabAvert vaccine subcutaneously instead of intramuscularly; Case reference number US-BN-2024-002415 is a spontaneous case initially received from a pharmacist via Med Communication (reference number: USBAV24-2177) on 29-Aug-2024 and concerns a 72-year-old female patient. The patient's medical history and concomitant medication details were not provided. *On unspecified date, the patient had rabies exposure, reported as awoken to bat flying around bedroom. As reported, the patient was not sure if bat bite occurred.* *On 16-Aug-2024, unknown amount of time after bat exposure,* the patient was vaccinated with the first dose of RabAvert *(batch number: FDP00555, expiry date: 01-Sep-2027), at a dose of one milliliter, via intramuscular use in right upper arm for bat exposure.* *On 18-Aug-2024, unknown amount of time after bat exposure,* the patient was vaccinated with the second dose of RabAvert *(batch number: FDP00555, expiry date: 01-Sep-2027), at a dose of one milliliter, via subcutaneous use in right upper arm (explicitly coded as 'inappropriate route of vaccination'). As reported, human factors (nurse misread the order) were contributed during the administration of RabAvert.* *On 22-Aug-2024, unknown amount of time after bat exposure,* the patient was vaccinated with the third dose of RabAvert *(batch number: FDP00543, expiry date: 01-Sep-2027), at a dose of one milliliter, via intramuscular use in right upper arm.* *On 29-Aug-2024, unknown amount of time after bat exposure, the patient was vaccinated with the fourth dose of RabAvert (batch number: FDP00552, expiry date: 01-Nov-2027), at a dose of one milliliter, via intramuscular use in right upper arm.* *On 03-Sep-2024, unknown amount of time after bat exposure, the patient was vaccinated with the fifth dose of RabAvert (batch number: FDP00543, expiry date: 01-Sep-2027), at a dose of one milliliter, via intramuscular use in left upper arm.* *As reported, the patient did not experience any adverse event due to RabAvert.* All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*). Follow up information received from a pharmacist on 11-Sep-2024: New information included added patient initials, RabAvert dosage information and confirmation on adverse event and contributing factors.; Reporter's Comments: A 72-year-old female patient was vaccinated with the second dose of RabAvert, subcutaneously, which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company convention. The patient did not experience any adverse event due to RabAvert. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 72-year-old female patient was vaccinated with the second dose of RabAvert, subcutaneously, which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company convention. The patient did not experience any adverse event due to RabAvert. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious. More
2847596 9 F ND 06/27/2025 COVID19
 PFIZER\BIONTECH
 LN7302
Product storage error Product storage error
Error during transport caused vaccine to be deemed invalid Error during transport caused vaccine to be deemed invalid
2847597 5 M ND 06/27/2025 COVID19
 PFIZER\BIONTECH
 LN7302
Product storage error Product storage error
Error during transport caused vaccine to be deemed invalid. Error during transport caused vaccine to be deemed invalid.
2847599 21 F NH 06/27/2025 TDAP
 SANOFI PASTEUR
 U8618AA
Extra dose administered Extra dose administered
Patient received Tdap dose on 6/27/25 as her previous PCP records indicated last dose was in October... Patient received Tdap dose on 6/27/25 as her previous PCP records indicated last dose was in October of 2015. After administration it was determined patient had received Tdap at the same facility one month prior 5/29/2025. More
๐Ÿ“‹ Privacy Policy & Data Disclaimer